Chong Kun Dang seeks overseas expansion

Published: 2013-07-29 06:59:00
Updated: 2013-07-29 06:59:00
Chong Kun Dang Pharmaceutical is aiming to go global with rosuvastain, a member of the drug class of statins.

The company on Thursday said in its regulatory filing that its rosuvastatin patent has received the green light from the U.S. Patent and Trademark Office.

The patent relates to a no...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.